In breast cancer, LOXL2 expression is negatively correlated with OS and metastasis-free survival (MFS) in patients with ER negative invasive breast cancer, whereas suppression of LOXL2 in mouse breast-cancer models impairs invasion and metastasis of breast cancer cells [58]. The gene discussed is LOXL2; the disease is invasive breast carcinoma.